A developed HPLC method for the determination of Alogliptin Benzoate and its potential impurities in bulk drug and tablets

A developed HPLC method for the determination of Alogliptin Benzoate and its potential impurities in bulk drug and tablets

Alogliptin (AGLT), active ingredient of Alogliptin Benzoate (AGLT-BZ), is a new dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type 2 diabetes. This study aimed to build a suitable method to determine the potential related substances in AGLT-BZ bulk drug and tablets. Seven related sub...

Full description

Bibliographic Details
Main Authors: Kun Zhang, Panqin Ma, Wenna Jing, Xiangrong Zhang
Format: Article
Language:English
Published: Elsevier 2015-04-01
Series:Asian Journal of Pharmaceutical Sciences
Subjects:
Alogliptin benzoate
Impurity
HPLC
Bulk drug
Commercial tablets
Online Access:http://www.sciencedirect.com/science/article/pii/S1818087615000112

Internet

http://www.sciencedirect.com/science/article/pii/S1818087615000112

Similar Items